Poisoning by, adverse effect of and underdosing of agents primarily affecting the gastrointestinal system (T47)

Browse all the diagnosis codes used for poisoning by, adverse effect of and underdosing of agents primarily affecting the gastrointestinal system (t47). For easy navigation, the diagnosis codes are sorted in alphabetical order and grouped by sections. Each section is clearly marked with its description, and the corresponding three-digit code range. This format makes it simple to browse diagnosis codes in this chapter or section and find what you're looking for. We've also added green checkmark icons to label billable codes, and red warning icons for non-billable ones. This makes it easy to identify which codes can be billed.

Clinical Information

1,4-alpha-Glucan Branching Enzyme - In glycogen or amylopectin synthesis, the enzyme that catalyzes the transfer of a segment of a 1,4-alpha-glucan chain to a primary hydroxy group in a similar glucan chain. EC 2.4.1.18.

Actinobacillus equuli - A genus of gram-negative bacteria in the genus ACTINOBACILLUS, which is pathogenic for HORSES and PIGS.

Aeromonas caviae - A species of gram-negative, facultatively anaerobic bacteria that is found in domestic and wild animals including birds, and fish. In humans it causes GASTROENTERITIS in young children and some adults.

Agrobacterium tumefaciens - A species of gram-negative, aerobic bacteria isolated from soil and the stems, leafs, and roots of plants. Some biotypes are pathogenic and cause the formation of PLANT TUMORS in a wide variety of higher plants. The species is a major research tool in biotechnology.

Aliivibrio fischeri - A species of gram-negative bacteria in the genus ALIIVIBRIO, which exhibits LUMINESCENCE. A. fischeri is found in a symbiotic relationship with the SQUID Euprymna scolopes.

alpha-Chlorohydrin - A chlorinated PROPANEDIOL with antifertility activity in males used as a chemosterilant in rodents.

Amylopectin - A highly branched glucan in starch.

Anthrax - An acute infection caused by the spore-forming bacteria BACILLUS ANTHRACIS. It commonly affects hoofed animals such as sheep and goats. Infection in humans often involves the skin (cutaneous anthrax), the lungs (inhalation anthrax), or the gastrointestinal tract. Anthrax is not contagious and can be treated with antibiotics.

Apomorphine - A derivative of morphine that is a dopamine D2 agonist. It is a powerful emetic and has been used for that effect in acute poisoning. It has also been used in the diagnosis and treatment of parkinsonism, but its adverse effects limit its use.

Bacillus - A genus of BACILLACEAE that are spore-forming, rod-shaped cells. Most species are saprophytic soil forms with only a few species being pathogenic.

Bacillus amyloliquefaciens - A non-pathogenic species of Bacillus that occurs in soil as well as some fermented vegetables and FERMENTED DAIRY PRODUCTS. It produces BACTERIOCINS and ANTIFUNGAL AGENTS and is used in FOOD PRESERVATION as well as a PROBIOTIC.

Bacillus anthracis - A species of bacteria that causes ANTHRAX in humans and animals.

Bacillus cereus - A species of rod-shaped bacteria that is a common soil saprophyte. Its spores are widespread and multiplication has been observed chiefly in foods. Contamination may lead to food poisoning.

Bacillus clausii - An alkalophilic species of Bacillus that occurs in soil. It produces ANTI-BACTERIAL AGENTS and is used as a PROBIOTIC.

Bacillus coagulans - A microaerophilic, LACTIC ACID producing species of Bacillus that occurs in FERMENTED FOODS. It also produces ANTI-INFECTIVE AGENTS and is used as a PROBIOTIC.

Bacillus firmus - A species of Bacillus that occurs in soil and marine sediments. Many strains are alkalophilic and able to metabolize HEAVY METALS; it may therefore be a useful species for ENVIRONMENTAL BIODEGRADATION.

Bacillus licheniformis - A species of Bacillus that occurs in soil and is frequently found on bird feathers. Some strains cause FOODBORNE DISEASE, whereas other strains produce ANTIFUNGAL AGENTS and ANTIBACTERIAL AGENTS and function as PROBIOTICS. This species can also produce enzymes for industrial applications.

Bacillus megaterium - A species of bacteria whose spores vary from round to elongate. It is a common soil saprophyte.

Bacillus Phages - Viruses whose host is Bacillus. Frequently encountered Bacillus phages include bacteriophage phi 29 and bacteriophage phi 105.

Bacillus pumilus - A species of Bacillus that occurs in soil, especially around the roots of some plants where it has anti-fungal and anti-nematode activities. It can also produce enzymes for industrial applications.

Bacillus subtilis - A species of gram-positive bacteria that is a common soil and water saprophyte.

Bacillus thuringiensis - A species of gram-positive bacteria which may be pathogenic for certain insects. It is used for the biological control of the Gypsy moth.

Bacillus thuringiensis Toxins - Endotoxins produced by BACILLUS THURINGIENSIS used in transgenic plants and insecticides. When eaten by a susceptible insect they are protease activated in the insect midgut resulting in death from bacterial septicemia.

BCG Vaccine - An active immunizing agent and a viable avirulent attenuated strain of MYCOBACTERIUM BOVIS, which confers immunity to mycobacterial infections. It is used also in immunotherapy of neoplasms due to its stimulation of antibodies and non-specific immunity.

Betaine - A naturally occurring compound that has been of interest for its role in osmoregulation. As a drug, betaine hydrochloride has been used as a source of hydrochloric acid in the treatment of hypochlorhydria. Betaine has also been used in the treatment of liver disorders, for hyperkalemia, for homocystinuria, and for gastrointestinal disturbances. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1341)

Betaine-Aldehyde Dehydrogenase - An NAD+ dependent enzyme that catalyzes the oxidation of betain aldehyde to BETAINE.

Betaine-Homocysteine S-Methyltransferase - A ZINC metalloenzyme that catalyzes the transfer of a methyl group from BETAINE to HOMOCYSTEINE to produce dimethylglycine and METHIONINE, respectively. This enzyme is a member of a family of ZINC-dependent METHYLTRANSFERASES that use THIOLS or selenols as methyl acceptors.

Bisacodyl - A diphenylmethane stimulant laxative used for the treatment of CONSTIPATION and for bowel evacuation. (From Martindale, The Extra Pharmacopoeia, 30th ed, p871)

Bordetella bronchiseptica - A species of BORDETELLA that is parasitic and pathogenic. It is found in the respiratory tract of domestic and wild mammalian animals and can be transmitted from animals to man. It is a common cause of bronchopneumonia in lower animals.

Bryonia - A plant genus of the family CUCURBITACEAE that is the source of bryodin 1 (a ribosome-inactivating protein).

Burimamide - An antagonist of histamine that appears to block both H2 and H3 histamine receptors. It has been used in the treatment of ulcers.

Carbenoxolone - An agent derived from licorice root. It is used for the treatment of digestive tract ulcers, especially in the stomach. Antidiuretic side effects are frequent, but otherwise the drug is low in toxicity.

Carbohydrate Binding Modules - Contiguous amino acid sequences within a carbohydrate-active enzyme with discrete folds having carbohydrate binding activity. They are classified into 43 different families based on AMINO ACID SEQUENCE, binding specificity, and structure.

Carboxymethylcellulose Sodium - A cellulose derivative which is a beta-(1,4)-D-glucopyranose polymer. It is used as a bulk laxative and as an emulsifier and thickener in cosmetics and pharmaceuticals and as a stabilizer for reagents.

Carrageenan - A water-soluble extractive mixture of sulfated polysaccharides from RED ALGAE. Chief sources are the Irish moss CHONDRUS CRISPUS (Carrageen), and Gigartina stellata. It is used as a stabilizer, for suspending COCOA in chocolate manufacture, and to clarify BEVERAGES.

Cellulose - A polysaccharide with glucose units linked as in CELLOBIOSE. It is the chief constituent of plant fibers, cotton being the purest natural form of the substance. As a raw material, it forms the basis for many derivatives used in chromatography, ion exchange materials, explosives manufacturing, and pharmaceutical preparations.

Cellulose 1,4-beta-Cellobiosidase - An exocellulase with specificity for the hydrolysis of 1,4-beta-D-glucosidic linkages in CELLULOSE and cellotetraose. It catalyzes the hydrolysis of terminal non-reducing ends of beta-D-glucosides with release of CELLOBIOSE.

Cellulose, Oxidized - A cellulose of varied carboxyl content retaining the fibrous structure. It is commonly used as a local hemostatic and as a matrix for normal blood coagulation.

Cephaelis - A plant genus of the family RUBIACEAE, order Rubiales, subclass Asteridae. Cephaelis ipecacuanha is the source of IPECAC.

Charcoal - An amorphous form of carbon prepared from the incomplete combustion of animal or vegetable matter, e.g., wood. The activated form of charcoal is used in the treatment of poisoning. (Grant & Hackh's Chemical Dictionary, 5th ed)

Chenodeoxycholic Acid - A bile acid, usually conjugated with either glycine or taurine. It acts as a detergent to solubilize fats for intestinal absorption and is reabsorbed by the small intestine. It is used as cholagogue, a choleretic laxative, and to prevent or dissolve gallstones.

Cholic Acid - A major primary bile acid produced in the liver and usually conjugated with glycine or taurine. It facilitates fat absorption and cholesterol excretion.

Cholic Acids - The 3 alpha,7 alpha,12 alpha-trihydroxy-5 beta-cholanic acid family of bile acids in man, usually conjugated with glycine or taurine. They act as detergents to solubilize fats for intestinal absorption, are reabsorbed by the small intestine, and are used as cholagogues and choleretics.

Cimetidine - A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output.

Cisapride - A substituted benzamide used for its prokinetic properties. It is used in the management of gastroesophageal reflux disease, functional dyspepsia, and other disorders associated with impaired gastrointestinal motility. (Martindale The Extra Pharmacopoeia, 31st ed)

Citric Acid - A key intermediate in metabolism. It is an acid compound found in citrus fruits. The salts of citric acid (citrates) can be used as anticoagulants due to their calcium chelating ability.

Citric Acid Cycle - A series of oxidative reactions in the breakdown of acetyl units derived from GLUCOSE; FATTY ACIDS; or AMINO ACIDS by means of tricarboxylic acid intermediates. The end products are CARBON DIOXIDE, water, and energy in the form of phosphate bonds.

Collodion - A nitrocellulose solution in ether and alcohol. Collodion has a wide range of uses in industry including applications in the manufacture of photographic film, in fibers, in lacquers, and in engraving and lithography. In medicine it is used as a drug solvent and a wound sealant.

Coronavirus Papain-Like Proteases - Papain-like proteases that occur in species of CORONAVIRIDAE. Some species have more than one papain-like protease gene.

Dehydrocholic Acid - A semisynthetic bile acid made from cholic acid. It is used as a cholagogue, hydrocholeretic, diuretic, and as a diagnostic aid.

Diphenoxylate - A MEPERIDINE congener used as an antidiarrheal, usually in combination with ATROPINE. At high doses, it acts like morphine. Its unesterified metabolite difenoxin has similar properties and is used similarly. It has little or no analgesic activity.

Electrophoresis, Cellulose Acetate - Electrophoresis in which cellulose acetate is the diffusion medium.

Enprostil - A synthetic PGE2 analog that has an inhibitory effect on gastric acid secretion, a mucoprotective effect, and a postprandial lowering effect on gastrin. It has been shown to be efficient and safe in the treatment of gastroduodenal ulcers.

Erwinia amylovora - A species of gram-negative bacteria, in the genus ERWINIA, causing a necrotic disease of plants.

Escherichia coli - A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc.

Famotidine - A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.

Geobacillus stearothermophilus - A species of GRAM-POSITIVE ENDOSPORE-FORMING BACTERIA in the family BACILLACEAE, found in soil, hot springs, Arctic waters, ocean sediments, and spoiled food products.

Glutamate Decarboxylase - A pyridoxal-phosphate protein that catalyzes the alpha-decarboxylation of L-glutamic acid to form gamma-aminobutyric acid and carbon dioxide. The enzyme is found in bacteria and in invertebrate and vertebrate nervous systems. It is the rate-limiting enzyme in determining GAMMA-AMINOBUTYRIC ACID levels in normal nervous tissues. The brain enzyme also acts on L-cysteate, L-cysteine sulfinate, and L-aspartate. EC 4.1.1.15.

Glutamates - Derivatives of GLUTAMIC ACID. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain the 2-aminopentanedioic acid structure.

Glutamic Acid - A non-essential amino acid naturally occurring in the L-form. Glutamic acid is the most common excitatory neurotransmitter in the CENTRAL NERVOUS SYSTEM.

Glycerol - A trihydroxy sugar alcohol that is an intermediate in carbohydrate and lipid metabolism. It is used as a solvent, emollient, pharmaceutical agent, or sweetening agent.

Glycerol Kinase - An enzyme that catalyzes the formation of glycerol 3-phosphate from ATP and glycerol. Dihydroxyacetone and L-glyceraldehyde can also act as acceptors; UTP and, in the case of the yeast enzyme, ITP and GTP can act as donors. It provides a way for glycerol derived from fats or glycerides to enter the glycolytic pathway. EC 2.7.1.30.

Glycerol-3-Phosphate Dehydrogenase (NAD+) - An NAD-dependent enzyme that catalyzes the oxidation of sn-glycerol 3-phosphate to glycerone phosphate.

Glycerol-3-Phosphate O-Acyltransferase - An enzyme that transfers acyl groups from acyl-CoA to glycerol-3-phosphate to form monoglyceride phosphates. It acts only with CoA derivatives of fatty acids of chain length above C-10. Also forms diglyceride phosphates. EC 2.3.1.15.

Glycerolphosphate Dehydrogenase - An enzyme that transfers acyl groups from acyl-CoA to glycerol-3-phosphate to form monoglyceride phosphates. It acts only with CoA derivatives of fatty acids of chain length above C-10. Also forms diglyceride phosphates. EC 2.3.1.15.

Glycerophosphates - Any salt or ester of glycerophosphoric acid.

Glyceryl Ethers - Compounds in which one or more of the three hydroxyl groups of glycerol are in ethereal linkage with a saturated or unsaturated aliphatic alcohol; one or two of the hydroxyl groups of glycerol may be esterified. These compounds have been found in various animal tissue.

Glycerylphosphorylcholine - A component of PHOSPHATIDYLCHOLINES or LECITHINS, in which the two hydroxy groups of GLYCEROL are esterified with fatty acids. (From Stedman, 26th ed)

Glycogen Storage Disease Type IV - An autosomal recessive metabolic disorder due to a deficiency in expression of glycogen branching enzyme 1 (alpha-1,4-glucan-6-alpha-glucosyltransferase), resulting in an accumulation of abnormal GLYCOGEN with long outer branches. Clinical features are MUSCLE HYPOTONIA and CIRRHOSIS. Death from liver disease usually occurs before age 2.

Guaifenesin - An expectorant that also has some muscle relaxing action. It is used in many cough preparations.

Haemophilus ducreyi - A species of HAEMOPHILUS that appears to be the pathogen or causative agent of the sexually transmitted disease, CHANCROID.

Ipecac - A syrup made from the dried rhizomes of two different species, CEPHAELIS ipecacuanha and C. acuminata. They contain EMETINE, cephaeline, psychotrine and other ISOQUINOLINES. Ipecac syrup is used widely as an emetic acting both locally on the gastric mucosa and centrally on the chemoreceptor trigger zone.

Kaolin - The most common mineral of a group of hydrated aluminum silicates, approximately H2Al2Si2O8-H2O. It is prepared for pharmaceutical and medicinal purposes by levigating with water to remove sand, etc. (From Merck Index, 11th ed) The name is derived from Kao-ling (Chinese: high ridge), the original site. (From Grant & Hackh's Chemical Dictionary, 5th ed)

Klebsiella oxytoca - A species of gram-negative bacteria causing URINARY TRACT INFECTIONS and SEPTICEMIA.

Klebsiella pneumoniae - Gram-negative, non-motile, capsulated, gas-producing rods found widely in nature and associated with urinary and respiratory infections in humans.

Lacticaseibacillus casei - A rod-shaped bacterium isolated from milk and cheese, dairy products and dairy environments, sour dough, cow dung, silage, and human mouth, human intestinal contents and stools, and the human vagina. L. casei is CATALASE positive.

Lacticaseibacillus paracasei - A species of Lacticaseibacillus that occurs in the GUT MICROBIOTA of healthy humans as well as FERMENTED DAIRY PRODUCTS and fermented vegetables. It is used as a PROBIOTIC.

Lacticaseibacillus rhamnosus - A species of gram-positive, rod-shaped bacteria used in PROBIOTICS.

Lactobacillus - A genus of gram-positive, microaerophilic, rod-shaped bacteria occurring widely in nature. Its species are also part of the many normal flora of the mouth, intestinal tract, and vagina of many mammals, including humans. Lactobacillus species are homofermentative and ferment a broad spectrum of carbohydrates often host-adapted but do not ferment PENTOSES. Most members were previously assigned to the Lactobacillus delbrueckii group. Pathogenicity from this genus is rare.

Lactobacillus acidophilus - A species of gram-positive, rod-shaped bacteria isolated from the intestinal tract of humans and animals, the human mouth, and vagina. This organism produces the fermented product, acidophilus milk.

Lactobacillus crispatus - A species of Lactobacillus that occurs in the human GASTROINTESTINAL TRACT and the VAGINA of healthy women. It produces LACTIC ACID and HYDROGEN PEROXIDE, and is used as a PROBIOTIC. It is also used for the treatment and prevention of BACTERIAL VAGINOSIS.

Lactobacillus delbrueckii - A species of gram-positive, rod-shaped, facultatively anaerobic bacteria. capable of producing LACTIC ACID. It is important in the manufacture of FERMENTED DAIRY PRODUCTS.

Lactobacillus gasseri - A species of Lactobacillus that occurs in the human ORAL MUCOSA; GASTROINTESTINAL TRACT; and VAGINA. It produces BACTERIOCINS, can modulate the immune response, and is used as a PROBIOTIC.

Lactobacillus helveticus - A species of gram-positive bacteria isolated from MILK and cheese-starter cultures.

Lactobacillus johnsonii - A species of Lactobacillus that occurs in the human GASTROINTESTINAL TRACT and VAGINA. It produces BACTERIOCINS and HYDROGEN PEROXIDE and is used as a PROBIOTIC.

Lactobacillus leichmannii - A species of gram-negative bacteria isolated from MILK, cheese, and compressed yeast.

Lactobacillus pentosus - A species of Lactobacillus that occurs in FERMENTED FOODS where its ability to produce LACTIC ACID; ANTI-INFECTIVE AGENTS; and BACTERIOCINS make it useful as a FOOD PRESERVATION agent. It is also used as a PROBIOTIC.

Lactobacillus plantarum - A species of rod-shaped, LACTIC ACID bacteria used in PROBIOTICS and SILAGE production.

Lactulose - A synthetic disaccharide used in the treatment of constipation and hepatic encephalopathy. It has also been used in the diagnosis of gastrointestinal disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p887)

Latilactobacillus sakei - A species of Lactobacillus that occurs in fermented meat and fish. It produces the BACTERIOCIN Sakacin P and is used for FOOD PRESERVATION and as a PROBIOTIC.

Levilactobacillus brevis - A species of gram-positive, rod-shaped LACTIC ACID bacteria that is frequently used as starter culture in SILAGE fermentation, sourdough, and lactic-acid-fermented types of beer and wine.

L-Iditol 2-Dehydrogenase - An alcohol oxidoreductase which catalyzes the oxidation of L-iditol to L-sorbose in the presence of NAD. It also acts on D-glucitol to form D-fructose. It also acts on other closely related sugar alcohols to form the corresponding sugar. EC 1.1.1.14

Ligilactobacillus salivarius - A species of Lactobacillus that occurs in the human GASTROINTESTINAL TRACT and ORAL MUCOSA. It produces BACTERIOCINS and is used as a PROBIOTIC.

Limosilactobacillus fermentum - A species of gram-positive, rod-shaped bacteria associated with DENTAL CARIES.

Limosilactobacillus reuteri - A species of gram-positive, rod-shaped LACTIC ACID bacteria found naturally in the human intestinal flora and BREAST MILK.

Loperamide - One of the long-acting synthetic ANTIDIARRHEALS; it is not significantly absorbed from the gut, and has no effect on the adrenergic system or central nervous system, but may antagonize histamine and interfere with acetylcholine release locally.

Malvaceae - The mallow family of the order MALVALES, subclass Dilleniidae, class Magnoliopsida. The common names of hollyhock and mallow are used for several genera of Malvaceae.

Mannitol - A diuretic and renal diagnostic aid related to sorbitol. It has little significant energy value as it is largely eliminated from the body before any metabolism can take place. It can be used to treat oliguria associated with kidney failure or other manifestations of inadequate renal function and has been used for determination of glomerular filtration rate. Mannitol is also commonly used as a research tool in cell biological studies, usually to control osmolarity.

Mannitol Dehydrogenases - Sugar alcohol dehydrogenases that have specificity for MANNITOL. Enzymes in this category are generally classified according to their preference for a specific reducing cofactor.

Mannitol Phosphates - Phosphoric acid esters of mannitol.

Mannomustine - Nitrogen mustard derivative alkylating agent used as antineoplastic. It causes severe bone marrow depression and is a powerful vesicant.

Methylcellulose - Methylester of cellulose. Methylcellulose is used as an emulsifying and suspending agent in cosmetics, pharmaceutics and the chemical industry. It is used therapeutically as a bulk laxative.

Metiamide - A histamine H2 receptor antagonist that is used as an anti-ulcer agent.

Misoprostol - A synthetic analog of natural prostaglandin E1. It produces a dose-related inhibition of gastric acid and pepsin secretion, and enhances mucosal resistance to injury. It is an effective anti-ulcer agent and also has oxytocic properties.

Monoacylglycerol Lipases - An enzyme that catalyzes the hydrolysis of glycerol monoesters of long-chain fatty acids EC 3.1.1.23.

Morganella morganii - A species of MORGANELLA formerly classified as a Proteus species. It is found in the feces of humans, dogs, other mammals, and reptiles. (From Bergey's Manual of Determinative Bacteriology, 9th ed)

Nizatidine - A histamine H2 receptor antagonist with low toxicity that inhibits gastric acid secretion. The drug is used for the treatment of duodenal ulcers.

Omeprazole - A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.

Paenibacillus polymyxa - A species of Paenibacillus formerly classified as Bacillus polymyxa that occurs in marine sediments and soil, especially around plant roots and RHIZOMES where it performs NITROGEN FIXATION. It has activity against several species of pathogenic bacteria and produces POLYMYXINS.

Pancreatin - A mammalian pancreatic extract composed of enzymes with protease, amylase and lipase activities. It is used as a digestant in pancreatic malfunction.

Pancrelipase - A preparation of hog pancreatic enzymes standardized for lipase content.

Papain - A proteolytic enzyme obtained from Carica papaya. It is also the name used for a purified mixture of papain and CHYMOPAPAIN that is used as a topical enzymatic debriding agent. EC 3.4.22.2.

Partial Thromboplastin Time - The time required for the appearance of FIBRIN strands following the mixing of PLASMA with phospholipid platelet substitute (e.g., crude cephalins, soybean phosphatides). It is a test of the intrinsic pathway (factors VIII, IX, XI, and XII) and the common pathway (fibrinogen, prothrombin, factors V and X) of BLOOD COAGULATION. It is used as a screening test and to monitor HEPARIN therapy.

Pectobacterium carotovorum - A species of gram-negative, facultatively anaerobic, rod-shaped bacteria that causes rotting, particularly of storage tissues, of a wide variety of plants and causes a vascular disease in CARROTS; and POTATO plants.

Phenolphthalein - An acid-base indicator which is colorless in acid solution, but turns pink to red as the solution becomes alkaline. It is used medicinally as a cathartic.

Phenolphthaleins - A family of 3,3-bis(p-hydroxyphenyl)phthalides. They are used as CATHARTICS, indicators, and COLORING AGENTS.

Phosphatidylglycerols - A nitrogen-free class of lipids present in animal and particularly plant tissues and composed of one mole of glycerol and 1 or 2 moles of phosphatidic acid. Members of this group differ from one another in the nature of the fatty acids released on hydrolysis.

Phospholipid Ethers - Phospholipids which have an alcohol moiety in ethereal linkage with a saturated or unsaturated aliphatic alcohol. They are usually derivatives of phosphoglycerols or phosphatidates. The other two alcohol groups of the glycerol backbone are usually in ester linkage. These compounds are widely distributed in animal tissues.

Pirenzepine - An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients.

Plasminogen - Precursor of plasmin (FIBRINOLYSIN). It is a single-chain beta-globulin of molecular weight 80-90,000 found mostly in association with fibrinogen in plasma; plasminogen activators change it to fibrinolysin. It is used in wound debriding and has been investigated as a thrombolytic agent.

Poloxamer - A nonionic polyoxyethylene-polyoxypropylene block co-polymer with the general formula HO(C2H4O)a(-C3H6O)b(C2H4O)aH. It is available in different grades which vary from liquids to solids. It is used as an emulsifying agent, solubilizing agent, surfactant, and wetting agent for antibiotics. Poloxamer is also used in ointment and suppository bases and as a tablet binder or coater. (Martindale The Extra Pharmacopoeia, 31st ed)

Proglumide - A drug that exerts an inhibitory effect on gastric secretion and reduces gastrointestinal motility. It is used clinically in the drug therapy of gastrointestinal ulcers.

Pseudomonas aeruginosa - A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection.

Pseudomonas fluorescens - A species of nonpathogenic fluorescent bacteria found in feces, sewage, soil, and water, and which liquefy gelatin.

Pseudomonas stutzeri - A species of gram-negative bacteria in the genus PSEUDOMONAS, containing multiple genomovars. It is distinguishable from other pseudomonad species by its ability to use MALTOSE and STARCH as sole carbon and energy sources. It can degrade ENVIRONMENTAL POLLUTANTS and has been used as a model organism to study denitrification.

Ranitidine - A non-imidazole blocker of those histamine receptors that mediate gastric secretion (H2 receptors). It is used to treat gastrointestinal ulcers.

RNA, Transfer, Glu - A transfer RNA which is specific for carrying glutamic acid to sites on the ribosomes in preparation for protein synthesis.

Saccharomyces boulardii - A species of Saccharomyces that is used as a PROBIOTIC, such as in the treatment of DIARRHEA and PSEUDOMEMBRANOUS ENTEROCOLITIS associated with CLOSTRIDIUM INFECTIONS.

Shigella dysenteriae - A species of gram-negative, facultatively anaerobic, rod-shaped bacteria that is extremely pathogenic and causes severe dysentery. Infection with this organism often leads to ulceration of the intestinal epithelium.

Simethicone - A poly(dimethylsiloxane) which is a polymer of 200-350 units of dimethylsiloxane, along with added silica gel. It is used as an antiflatulent, surfactant, and ointment base.

Sorbitol - A polyhydric alcohol with about half the sweetness of sucrose. Sorbitol occurs naturally and is also produced synthetically from glucose. It was formerly used as a diuretic and may still be used as a laxative and in irrigating solutions for some surgical procedures. It is also used in many manufacturing processes, as a pharmaceutical aid, and in several research applications.

Sterculia - A plant genus of the family STERCULIACEAE. S. urens is the source of KARAYA GUM which is sometimes called Indian tragacanth, which is different from the true TRAGACANTH which comes from ASTRAGALUS GUMMIFER.

Subtilisins - A family of SERINE ENDOPEPTIDASES isolated from Bacillus subtilis. EC 3.4.21.-

Sucralfate - A basic aluminum complex of sulfated sucrose.

Teichoic Acids - Bacterial polysaccharides that are rich in phosphodiester linkages. They are the major components of the cell walls and membranes of many bacteria.

Triolein - (Z)-9-Octadecenoic acid 1,2,3-propanetriyl ester.

Triose Sugar Alcohols - Sugar alcohol molecules that contain three carbons.

Vibrio cholerae - The etiologic agent of CHOLERA.

Xanthomonas campestris - A species of gram-negative, aerobic bacteria that is pathogenic for plants.

Yersinia pestis - The etiologic agent of PLAGUE in man, rats, ground squirrels, and other rodents.

Instructional Notations

7th Character Note

Certain ICD-10-CM categories have applicable 7th characters. The applicable 7th character is required for all codes within the category, or as the notes in the Tabular List instruct. The 7th character must always be the 7th character in the data field. If a code that requires a 7th character is not 6 characters, a placeholder X must be used to fill in the empty characters.

  • The appropriate 7th character is to be added to each code from category T47

7th Character

Indicates that a seventh character is to be assigned to codes in a subcategory.

  • A - initial encounter
  • D - subsequent encounter
  • S - sequela
  • Injury, poisoning and certain other consequences of external causes (S00–T88)

    • Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances (T36-T50)

        • Poisoning by, adverse effect of and underdosing of agents primarily affecting the gastrointestinal system (T47)

        • T47 Poisoning by, adverse effect of and underdosing of agents primarily affecting the gastrointestinal system
        • T47.0 Poisoning by, adverse effect of and underdosing of histamine H2-receptor blockers
        • T47.0X Poisoning by, adverse effect of and underdosing of histamine H2-receptor blockers
        • T47.0X1 Poisoning by histamine H2-receptor blockers, accidental (unintentional)
        • T47.0X1A Poisoning by histamine H2-receptor blockers, accidental (unintentional), initial encounter
        • T47.0X1D Poisoning by histamine H2-receptor blockers, accidental (unintentional), subsequent encounter
        • T47.0X1S Poisoning by histamine H2-receptor blockers, accidental (unintentional), sequela
        • T47.0X2 Poisoning by histamine H2-receptor blockers, intentional self-harm
        • T47.0X2A Poisoning by histamine H2-receptor blockers, intentional self-harm, initial encounter
        • T47.0X2D Poisoning by histamine H2-receptor blockers, intentional self-harm, subsequent encounter
        • T47.0X2S Poisoning by histamine H2-receptor blockers, intentional self-harm, sequela
        • T47.0X3 Poisoning by histamine H2-receptor blockers, assault
        • T47.0X3A Poisoning by histamine H2-receptor blockers, assault, initial encounter
        • T47.0X3D Poisoning by histamine H2-receptor blockers, assault, subsequent encounter
        • T47.0X3S Poisoning by histamine H2-receptor blockers, assault, sequela
        • T47.0X4 Poisoning by histamine H2-receptor blockers, undetermined
        • T47.0X4A Poisoning by histamine H2-receptor blockers, undetermined, initial encounter
        • T47.0X4D Poisoning by histamine H2-receptor blockers, undetermined, subsequent encounter
        • T47.0X4S Poisoning by histamine H2-receptor blockers, undetermined, sequela
        • T47.0X5 Adverse effect of histamine H2-receptor blockers
        • T47.0X5A Adverse effect of histamine H2-receptor blockers, initial encounter
        • T47.0X5D Adverse effect of histamine H2-receptor blockers, subsequent encounter
        • T47.0X5S Adverse effect of histamine H2-receptor blockers, sequela
        • T47.0X6 Underdosing of histamine H2-receptor blockers
        • T47.0X6A Underdosing of histamine H2-receptor blockers, initial encounter
        • T47.0X6D Underdosing of histamine H2-receptor blockers, subsequent encounter
        • T47.0X6S Underdosing of histamine H2-receptor blockers, sequela
        • T47.1 Poisoning by, adverse effect of and underdosing of other antacids and anti-gastric-secretion drugs
        • T47.1X Poisoning by, adverse effect of and underdosing of other antacids and anti-gastric-secretion drugs
        • T47.1X1 Poisoning by other antacids and anti-gastric-secretion drugs, accidental (unintentional)
        • T47.1X1A Poisoning by other antacids and anti-gastric-secretion drugs, accidental (unintentional), initial encounter
        • T47.1X1D Poisoning by other antacids and anti-gastric-secretion drugs, accidental (unintentional), subsequent encounter
        • T47.1X1S Poisoning by other antacids and anti-gastric-secretion drugs, accidental (unintentional), sequela
        • T47.1X2 Poisoning by other antacids and anti-gastric-secretion drugs, intentional self-harm
        • T47.1X2A Poisoning by other antacids and anti-gastric-secretion drugs, intentional self-harm, initial encounter
        • T47.1X2D Poisoning by other antacids and anti-gastric-secretion drugs, intentional self-harm, subsequent encounter
        • T47.1X2S Poisoning by other antacids and anti-gastric-secretion drugs, intentional self-harm, sequela
        • T47.1X3 Poisoning by other antacids and anti-gastric-secretion drugs, assault
        • T47.1X3A Poisoning by other antacids and anti-gastric-secretion drugs, assault, initial encounter
        • T47.1X3D Poisoning by other antacids and anti-gastric-secretion drugs, assault, subsequent encounter
        • T47.1X3S Poisoning by other antacids and anti-gastric-secretion drugs, assault, sequela
        • T47.1X4 Poisoning by other antacids and anti-gastric-secretion drugs, undetermined
        • T47.1X4A Poisoning by other antacids and anti-gastric-secretion drugs, undetermined, initial encounter
        • T47.1X4D Poisoning by other antacids and anti-gastric-secretion drugs, undetermined, subsequent encounter
        • T47.1X4S Poisoning by other antacids and anti-gastric-secretion drugs, undetermined, sequela
        • T47.1X5 Adverse effect of other antacids and anti-gastric-secretion drugs
        • T47.1X5A Adverse effect of other antacids and anti-gastric-secretion drugs, initial encounter
        • T47.1X5D Adverse effect of other antacids and anti-gastric-secretion drugs, subsequent encounter
        • T47.1X5S Adverse effect of other antacids and anti-gastric-secretion drugs, sequela
        • T47.1X6 Underdosing of other antacids and anti-gastric-secretion drugs
        • T47.1X6A Underdosing of other antacids and anti-gastric-secretion drugs, initial encounter
        • T47.1X6D Underdosing of other antacids and anti-gastric-secretion drugs, subsequent encounter
        • T47.1X6S Underdosing of other antacids and anti-gastric-secretion drugs, sequela
        • T47.2 Poisoning by, adverse effect of and underdosing of stimulant laxatives
        • T47.2X Poisoning by, adverse effect of and underdosing of stimulant laxatives
        • T47.2X1 Poisoning by stimulant laxatives, accidental (unintentional)
        • T47.2X1A Poisoning by stimulant laxatives, accidental (unintentional), initial encounter
        • T47.2X1D Poisoning by stimulant laxatives, accidental (unintentional), subsequent encounter
        • T47.2X1S Poisoning by stimulant laxatives, accidental (unintentional), sequela
        • T47.2X2 Poisoning by stimulant laxatives, intentional self-harm
        • T47.2X2A Poisoning by stimulant laxatives, intentional self-harm, initial encounter
        • T47.2X2D Poisoning by stimulant laxatives, intentional self-harm, subsequent encounter
        • T47.2X2S Poisoning by stimulant laxatives, intentional self-harm, sequela
        • T47.2X3 Poisoning by stimulant laxatives, assault
        • T47.2X3A Poisoning by stimulant laxatives, assault, initial encounter
        • T47.2X3D Poisoning by stimulant laxatives, assault, subsequent encounter
        • T47.2X3S Poisoning by stimulant laxatives, assault, sequela
        • T47.2X4 Poisoning by stimulant laxatives, undetermined
        • T47.2X4A Poisoning by stimulant laxatives, undetermined, initial encounter
        • T47.2X4D Poisoning by stimulant laxatives, undetermined, subsequent encounter
        • T47.2X4S Poisoning by stimulant laxatives, undetermined, sequela
        • T47.2X5 Adverse effect of stimulant laxatives
        • T47.2X5A Adverse effect of stimulant laxatives, initial encounter
        • T47.2X5D Adverse effect of stimulant laxatives, subsequent encounter
        • T47.2X5S Adverse effect of stimulant laxatives, sequela
        • T47.2X6 Underdosing of stimulant laxatives
        • T47.2X6A Underdosing of stimulant laxatives, initial encounter
        • T47.2X6D Underdosing of stimulant laxatives, subsequent encounter
        • T47.2X6S Underdosing of stimulant laxatives, sequela
        • T47.3 Poisoning by, adverse effect of and underdosing of saline and osmotic laxatives
        • T47.3X Poisoning by and adverse effect of saline and osmotic laxatives
        • T47.3X1 Poisoning by saline and osmotic laxatives, accidental (unintentional)
        • T47.3X1A Poisoning by saline and osmotic laxatives, accidental (unintentional), initial encounter
        • T47.3X1D Poisoning by saline and osmotic laxatives, accidental (unintentional), subsequent encounter
        • T47.3X1S Poisoning by saline and osmotic laxatives, accidental (unintentional), sequela
        • T47.3X2 Poisoning by saline and osmotic laxatives, intentional self-harm
        • T47.3X2A Poisoning by saline and osmotic laxatives, intentional self-harm, initial encounter
        • T47.3X2D Poisoning by saline and osmotic laxatives, intentional self-harm, subsequent encounter
        • T47.3X2S Poisoning by saline and osmotic laxatives, intentional self-harm, sequela
        • T47.3X3 Poisoning by saline and osmotic laxatives, assault
        • T47.3X3A Poisoning by saline and osmotic laxatives, assault, initial encounter
        • T47.3X3D Poisoning by saline and osmotic laxatives, assault, subsequent encounter
        • T47.3X3S Poisoning by saline and osmotic laxatives, assault, sequela
        • T47.3X4 Poisoning by saline and osmotic laxatives, undetermined
        • T47.3X4A Poisoning by saline and osmotic laxatives, undetermined, initial encounter
        • T47.3X4D Poisoning by saline and osmotic laxatives, undetermined, subsequent encounter
        • T47.3X4S Poisoning by saline and osmotic laxatives, undetermined, sequela
        • T47.3X5 Adverse effect of saline and osmotic laxatives
        • T47.3X5A Adverse effect of saline and osmotic laxatives, initial encounter
        • T47.3X5D Adverse effect of saline and osmotic laxatives, subsequent encounter
        • T47.3X5S Adverse effect of saline and osmotic laxatives, sequela
        • T47.3X6 Underdosing of saline and osmotic laxatives
        • T47.3X6A Underdosing of saline and osmotic laxatives, initial encounter
        • T47.3X6D Underdosing of saline and osmotic laxatives, subsequent encounter
        • T47.3X6S Underdosing of saline and osmotic laxatives, sequela
        • T47.4 Poisoning by, adverse effect of and underdosing of other laxatives
        • T47.4X Poisoning by, adverse effect of and underdosing of other laxatives
        • T47.4X1 Poisoning by other laxatives, accidental (unintentional)
        • T47.4X1A Poisoning by other laxatives, accidental (unintentional), initial encounter
        • T47.4X1D Poisoning by other laxatives, accidental (unintentional), subsequent encounter
        • T47.4X1S Poisoning by other laxatives, accidental (unintentional), sequela
        • T47.4X2 Poisoning by other laxatives, intentional self-harm
        • T47.4X2A Poisoning by other laxatives, intentional self-harm, initial encounter
        • T47.4X2D Poisoning by other laxatives, intentional self-harm, subsequent encounter
        • T47.4X2S Poisoning by other laxatives, intentional self-harm, sequela
        • T47.4X3 Poisoning by other laxatives, assault
        • T47.4X3A Poisoning by other laxatives, assault, initial encounter
        • T47.4X3D Poisoning by other laxatives, assault, subsequent encounter
        • T47.4X3S Poisoning by other laxatives, assault, sequela
        • T47.4X4 Poisoning by other laxatives, undetermined
        • T47.4X4A Poisoning by other laxatives, undetermined, initial encounter
        • T47.4X4D Poisoning by other laxatives, undetermined, subsequent encounter
        • T47.4X4S Poisoning by other laxatives, undetermined, sequela
        • T47.4X5 Adverse effect of other laxatives
        • T47.4X5A Adverse effect of other laxatives, initial encounter
        • T47.4X5D Adverse effect of other laxatives, subsequent encounter
        • T47.4X5S Adverse effect of other laxatives, sequela
        • T47.4X6 Underdosing of other laxatives
        • T47.4X6A Underdosing of other laxatives, initial encounter
        • T47.4X6D Underdosing of other laxatives, subsequent encounter
        • T47.4X6S Underdosing of other laxatives, sequela
        • T47.5 Poisoning by, adverse effect of and underdosing of digestants
        • T47.5X Poisoning by, adverse effect of and underdosing of digestants
        • T47.5X1 Poisoning by digestants, accidental (unintentional)
        • T47.5X1A Poisoning by digestants, accidental (unintentional), initial encounter
        • T47.5X1D Poisoning by digestants, accidental (unintentional), subsequent encounter
        • T47.5X1S Poisoning by digestants, accidental (unintentional), sequela
        • T47.5X2 Poisoning by digestants, intentional self-harm
        • T47.5X2A Poisoning by digestants, intentional self-harm, initial encounter
        • T47.5X2D Poisoning by digestants, intentional self-harm, subsequent encounter
        • T47.5X2S Poisoning by digestants, intentional self-harm, sequela
        • T47.5X3 Poisoning by digestants, assault
        • T47.5X3A Poisoning by digestants, assault, initial encounter
        • T47.5X3D Poisoning by digestants, assault, subsequent encounter
        • T47.5X3S Poisoning by digestants, assault, sequela
        • T47.5X4 Poisoning by digestants, undetermined
        • T47.5X4A Poisoning by digestants, undetermined, initial encounter
        • T47.5X4D Poisoning by digestants, undetermined, subsequent encounter
        • T47.5X4S Poisoning by digestants, undetermined, sequela
        • T47.5X5 Adverse effect of digestants
        • T47.5X5A Adverse effect of digestants, initial encounter
        • T47.5X5D Adverse effect of digestants, subsequent encounter
        • T47.5X5S Adverse effect of digestants, sequela
        • T47.5X6 Underdosing of digestants
        • T47.5X6A Underdosing of digestants, initial encounter
        • T47.5X6D Underdosing of digestants, subsequent encounter
        • T47.5X6S Underdosing of digestants, sequela
        • T47.6 Poisoning by, adverse effect of and underdosing of antidiarrheal drugs
        • T47.6X Poisoning by, adverse effect of and underdosing of antidiarrheal drugs
        • T47.6X1 Poisoning by antidiarrheal drugs, accidental (unintentional)
        • T47.6X1A Poisoning by antidiarrheal drugs, accidental (unintentional), initial encounter
        • T47.6X1D Poisoning by antidiarrheal drugs, accidental (unintentional), subsequent encounter
        • T47.6X1S Poisoning by antidiarrheal drugs, accidental (unintentional), sequela
        • T47.6X2 Poisoning by antidiarrheal drugs, intentional self-harm
        • T47.6X2A Poisoning by antidiarrheal drugs, intentional self-harm, initial encounter
        • T47.6X2D Poisoning by antidiarrheal drugs, intentional self-harm, subsequent encounter
        • T47.6X2S Poisoning by antidiarrheal drugs, intentional self-harm, sequela
        • T47.6X3 Poisoning by antidiarrheal drugs, assault
        • T47.6X3A Poisoning by antidiarrheal drugs, assault, initial encounter
        • T47.6X3D Poisoning by antidiarrheal drugs, assault, subsequent encounter
        • T47.6X3S Poisoning by antidiarrheal drugs, assault, sequela
        • T47.6X4 Poisoning by antidiarrheal drugs, undetermined
        • T47.6X4A Poisoning by antidiarrheal drugs, undetermined, initial encounter
        • T47.6X4D Poisoning by antidiarrheal drugs, undetermined, subsequent encounter
        • T47.6X4S Poisoning by antidiarrheal drugs, undetermined, sequela
        • T47.6X5 Adverse effect of antidiarrheal drugs
        • T47.6X5A Adverse effect of antidiarrheal drugs, initial encounter
        • T47.6X5D Adverse effect of antidiarrheal drugs, subsequent encounter
        • T47.6X5S Adverse effect of antidiarrheal drugs, sequela
        • T47.6X6 Underdosing of antidiarrheal drugs
        • T47.6X6A Underdosing of antidiarrheal drugs, initial encounter
        • T47.6X6D Underdosing of antidiarrheal drugs, subsequent encounter
        • T47.6X6S Underdosing of antidiarrheal drugs, sequela
        • T47.7 Poisoning by, adverse effect of and underdosing of emetics
        • T47.7X Poisoning by, adverse effect of and underdosing of emetics
        • T47.7X1 Poisoning by emetics, accidental (unintentional)
        • T47.7X1A Poisoning by emetics, accidental (unintentional), initial encounter
        • T47.7X1D Poisoning by emetics, accidental (unintentional), subsequent encounter
        • T47.7X1S Poisoning by emetics, accidental (unintentional), sequela
        • T47.7X2 Poisoning by emetics, intentional self-harm
        • T47.7X2A Poisoning by emetics, intentional self-harm, initial encounter
        • T47.7X2D Poisoning by emetics, intentional self-harm, subsequent encounter
        • T47.7X2S Poisoning by emetics, intentional self-harm, sequela
        • T47.7X3 Poisoning by emetics, assault
        • T47.7X3A Poisoning by emetics, assault, initial encounter
        • T47.7X3D Poisoning by emetics, assault, subsequent encounter
        • T47.7X3S Poisoning by emetics, assault, sequela
        • T47.7X4 Poisoning by emetics, undetermined
        • T47.7X4A Poisoning by emetics, undetermined, initial encounter
        • T47.7X4D Poisoning by emetics, undetermined, subsequent encounter
        • T47.7X4S Poisoning by emetics, undetermined, sequela
        • T47.7X5 Adverse effect of emetics
        • T47.7X5A Adverse effect of emetics, initial encounter
        • T47.7X5D Adverse effect of emetics, subsequent encounter
        • T47.7X5S Adverse effect of emetics, sequela
        • T47.7X6 Underdosing of emetics
        • T47.7X6A Underdosing of emetics, initial encounter
        • T47.7X6D Underdosing of emetics, subsequent encounter
        • T47.7X6S Underdosing of emetics, sequela
        • T47.8 Poisoning by, adverse effect of and underdosing of other agents primarily affecting gastrointestinal system
        • T47.8X Poisoning by, adverse effect of and underdosing of other agents primarily affecting gastrointestinal system
        • T47.8X1 Poisoning by other agents primarily affecting gastrointestinal system, accidental (unintentional)
        • T47.8X1A Poisoning by other agents primarily affecting gastrointestinal system, accidental (unintentional), initial encounter
        • T47.8X1D Poisoning by other agents primarily affecting gastrointestinal system, accidental (unintentional), subsequent encounter
        • T47.8X1S Poisoning by other agents primarily affecting gastrointestinal system, accidental (unintentional), sequela
        • T47.8X2 Poisoning by other agents primarily affecting gastrointestinal system, intentional self-harm
        • T47.8X2A Poisoning by other agents primarily affecting gastrointestinal system, intentional self-harm, initial encounter
        • T47.8X2D Poisoning by other agents primarily affecting gastrointestinal system, intentional self-harm, subsequent encounter
        • T47.8X2S Poisoning by other agents primarily affecting gastrointestinal system, intentional self-harm, sequela
        • T47.8X3 Poisoning by other agents primarily affecting gastrointestinal system, assault
        • T47.8X3A Poisoning by other agents primarily affecting gastrointestinal system, assault, initial encounter
        • T47.8X3D Poisoning by other agents primarily affecting gastrointestinal system, assault, subsequent encounter
        • T47.8X3S Poisoning by other agents primarily affecting gastrointestinal system, assault, sequela
        • T47.8X4 Poisoning by other agents primarily affecting gastrointestinal system, undetermined
        • T47.8X4A Poisoning by other agents primarily affecting gastrointestinal system, undetermined, initial encounter
        • T47.8X4D Poisoning by other agents primarily affecting gastrointestinal system, undetermined, subsequent encounter
        • T47.8X4S Poisoning by other agents primarily affecting gastrointestinal system, undetermined, sequela
        • T47.8X5 Adverse effect of other agents primarily affecting gastrointestinal system
        • T47.8X5A Adverse effect of other agents primarily affecting gastrointestinal system, initial encounter
        • T47.8X5D Adverse effect of other agents primarily affecting gastrointestinal system, subsequent encounter
        • T47.8X5S Adverse effect of other agents primarily affecting gastrointestinal system, sequela
        • T47.8X6 Underdosing of other agents primarily affecting gastrointestinal system
        • T47.8X6A Underdosing of other agents primarily affecting gastrointestinal system, initial encounter
        • T47.8X6D Underdosing of other agents primarily affecting gastrointestinal system, subsequent encounter
        • T47.8X6S Underdosing of other agents primarily affecting gastrointestinal system, sequela
        • T47.9 Poisoning by, adverse effect of and underdosing of unspecified agents primarily affecting the gastrointestinal system
        • T47.91 Poisoning by unspecified agents primarily affecting the gastrointestinal system, accidental (unintentional)
        • T47.91XA Poisoning by unspecified agents primarily affecting the gastrointestinal system, accidental (unintentional), initial encounter
        • T47.91XD Poisoning by unspecified agents primarily affecting the gastrointestinal system, accidental (unintentional), subsequent encounter
        • T47.91XS Poisoning by unspecified agents primarily affecting the gastrointestinal system, accidental (unintentional), sequela
        • T47.92 Poisoning by unspecified agents primarily affecting the gastrointestinal system, intentional self-harm
        • T47.92XA Poisoning by unspecified agents primarily affecting the gastrointestinal system, intentional self-harm, initial encounter
        • T47.92XD Poisoning by unspecified agents primarily affecting the gastrointestinal system, intentional self-harm, subsequent encounter
        • T47.92XS Poisoning by unspecified agents primarily affecting the gastrointestinal system, intentional self-harm, sequela
        • T47.93 Poisoning by unspecified agents primarily affecting the gastrointestinal system, assault
        • T47.93XA Poisoning by unspecified agents primarily affecting the gastrointestinal system, assault, initial encounter
        • T47.93XD Poisoning by unspecified agents primarily affecting the gastrointestinal system, assault, subsequent encounter
        • T47.93XS Poisoning by unspecified agents primarily affecting the gastrointestinal system, assault, sequela
        • T47.94 Poisoning by unspecified agents primarily affecting the gastrointestinal system, undetermined
        • T47.94XA Poisoning by unspecified agents primarily affecting the gastrointestinal system, undetermined, initial encounter
        • T47.94XD Poisoning by unspecified agents primarily affecting the gastrointestinal system, undetermined, subsequent encounter
        • T47.94XS Poisoning by unspecified agents primarily affecting the gastrointestinal system, undetermined, sequela
        • T47.95 Adverse effect of unspecified agents primarily affecting the gastrointestinal system
        • T47.95XA Adverse effect of unspecified agents primarily affecting the gastrointestinal system, initial encounter
        • T47.95XD Adverse effect of unspecified agents primarily affecting the gastrointestinal system, subsequent encounter
        • T47.95XS Adverse effect of unspecified agents primarily affecting the gastrointestinal system, sequela
        • T47.96 Underdosing of unspecified agents primarily affecting the gastrointestinal system
        • T47.96XA Underdosing of unspecified agents primarily affecting the gastrointestinal system, initial encounter
        • T47.96XD Underdosing of unspecified agents primarily affecting the gastrointestinal system, subsequent encounter
        • T47.96XS Underdosing of unspecified agents primarily affecting the gastrointestinal system, sequela